Back to top
Prof Nico Wulffraat

Prof Nico Wulffraat

Paediatric rheumatologist and immunologist

Professor Nico Wulffraat is a paediatric rheumatologist and immunologist and full professor within the Department of Paediatrics, Subunit Paediatric Immunology and Rheumatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht, The Netherlands.

 

Professor Wulffraat completed his medical degree at the Free University, Amsterdam, The Netherlands, and was later awarded a PhD from the same institution. His research interests focus on paediatric rheumatology, and he set up the European project Pharmachild and the European project SHARE on clinical guidelines in paediatric rheumatology. Additionally, Professor Wulffraat is the coordinator of the European Reference Network (ERN) RITA.

 

Professor Wulffraat is a member of committees such as the Gezondheidsraad Advies CVS (chronic fatigue syndrome) and the Evaluatie Beoordeling NFU Expertisecentra. He has also contributed to over 330 peer-reviewed papers.

0 resources
You are currently seeing only Dermatology content
Image
Video_15_03.31.png
Video41:11 min
Navigating the new European S2k guidelines for hidradenitis suppurativa: How will they change your clinical practice?

Unlock the European S2k HS guidelines. Prof. Tzellos and Prof. Bechara share expert insights and implications of the updated guidelines

EU-BK-2500021
Image
Video_14_02.02.png
Video6:55 min
Setting up MDT care in HS: Learning from psoriasis

Establishing a multidisciplinary team to alleviate disease burden and optimise patient outcomes, using the principles of value-based healthcare

EU-DA-2400507
Image
250715_Use of imaging in HS management_thumbnail Med Hub.png
Video6:30 min
Use of imaging in HS management

Transformative role of ultrasound and magnetic resonance imaging in HS management, and how AI-driven technologies may enhance disease characterisation

EU-DA-2400506
Image
Video_12_1.51.png
Video4:25 min
Evidence-based approach to medical management based on the European guidelines for HS

Latest evidence-based strategies for effective HS medical management including antibiotics and biologic therapy

EU-BK-2400332